Genomic Epidemiology of Carbapenem- and Colistin-Resistant Klebsiella pneumoniae Isolates From Serbia: Predominance of ST101 Strains Carrying a Novel OXA-48 Plasmid

Frontiers in Microbiology
Mattia PalmieriAlex van Belkum

Abstract

Klebsiella pneumoniae is a major cause of severe healthcare-associated infections and often shows MDR phenotypes. Carbapenem resistance is frequent, and colistin represents a key molecule to treat infections caused by such isolates. Here we evaluated the antimicrobial resistance (AMR) mechanisms and the genomic epidemiology of clinical K. pneumoniae isolates from Serbia. Consecutive non-replicate K. pneumoniae clinical isolates (n = 2,298) were collected from seven hospitals located in five Serbian cities and tested for carbapenem resistance by disk diffusion. Isolates resistant to at least one carbapenem (n = 426) were further tested for colistin resistance with Etest or Vitek2. Broth microdilution (BMD) was performed to confirm the colistin resistance phenotype, and colistin-resistant isolates (N = 45, 10.6%) were characterized by Vitek2 and whole genome sequencing. Three different clonal groups (CGs) were observed: CG101 (ST101, N = 38), CG258 (ST437, N = 4; ST340, N = 1; ST258, N = 1) and CG17 (ST336, N = 1). mcr genes, encoding for acquired colistin resistance, were not observed, while all the genomes presented mutations previously associated with colistin resistance. In particular, all strains had a mutated MgrB, with Mgr...Continue Reading

References

Mar 21, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·T Y Tan, S Y Ng
Feb 1, 2011·Bioinformatics·Mitchell J SullivanScott A Beatson
Aug 10, 2011·BMC Genomics·Nabil-Fareed AlikhanScott A Beatson
Apr 18, 2012·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Anton BankevichPavel A Pevzner
Jul 12, 2012·The Journal of Antimicrobial Chemotherapy·Ea ZankariMette Voldby Larsen
Aug 10, 2013·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·A PotronP Nordmann
Apr 30, 2014·Antimicrobial Agents and Chemotherapy·Alessandra CarattoliHenrik Hasman
Aug 16, 2014·International Journal of Antimicrobial Agents·Salome N SeiffertAndrea Endimiani
Feb 19, 2015·Antimicrobial Agents and Chemotherapy·Yi-Hsiang ChengJin-Town Wang
May 19, 2016·Emerging Infectious Diseases·Patrice NordmannLaurent Poirel
Jun 17, 2016·Microbiology and Molecular Biology Reviews : MMBR·Michelle K Paczosa, Joan Mecsas
Aug 31, 2016·Expert Opinion on Drug Metabolism & Toxicology·Ilias KaraiskosHelen Giamarellou
Nov 22, 2016·The Lancet Infectious Diseases·Hajo GrundmannUNKNOWN European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) Working Group
Mar 1, 2017·Antimicrobial Agents and Chemotherapy·Katarina NovovićBranko Jovčić
Mar 30, 2017·Microbial Genomics·Kelly L WyresKathryn E Holt
Apr 5, 2017·Antimicrobial Agents and Chemotherapy·Yi-Yun LiuYohei Doi
May 19, 2017·FEMS Microbiology Reviews·Shiri Navon-VeneziaAlessandra Carattoli
Jun 9, 2017·PLoS Computational Biology·Ryan R WickKathryn E Holt
Feb 8, 2018·The Journal of Antimicrobial Chemotherapy·Fusun CanOnder Ergonul
Mar 12, 2018·Trends in Microbiology·Jian SunYoujun Feng
Aug 15, 2018·Antimicrobial Agents and Chemotherapy·Adam StewartDavid Paterson
Sep 13, 2018·Expert Review of Anti-infective Therapy·Matteo BassettiAlessandro Russo

❮ Previous
Next ❯

Datasets Mentioned

BETA
PRJNA449293
1
MN218814

Methods Mentioned

BETA
MinION sequencing

Software Mentioned

FastQC
Easyfig
PlasmidFinder
BLAST +
BLAST
iTol
ncbi
mlst
SPAdes
parsnp

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.